Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.25B |
| 2 |
Microsoft
MSFT
|
+$1.39B |
| 3 |
Amazon
AMZN
|
+$1.26B |
| 4 |
Apple
AAPL
|
+$1.18B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$505M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$198M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
General Motors
GM
|
+$121M |
Sector Composition
| 1 | Technology | 29.5% |
| 2 | Financials | 12.9% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Appian
APPN
$2.3B
| $37.5M | ﹤0.01% |
938,539
+29,339
| +3% | +$1.17M |
|
1552
Protagonist Therapeutics
PTGX
$3.67B
| $37.4M | ﹤0.01% |
1,293,739
+45,455
| +4% | +$1.32M |
|
1553
Leonardo DRS
DRS
$11.2B
| $37.4M | ﹤0.01% |
1,692,156
+46,475
| +3% | +$1.03M |
|
1554
Descartes Systems
DSGX
$9.11B
| $37.4M | ﹤0.01% |
406,742
+15,712
| +4% | +$1.44M |
|
1555
Global Net Lease
GNL
$1.83B
| $37.2M | ﹤0.01% |
4,786,782
+143,032
| +3% | +$1.11M |
|
1556
American Woodmark
AMWD
$979M
| $37.2M | ﹤0.01% |
365,747
+6,010
| +2% | +$611K |
|
1557
Dyne Therapeutics
DYN
$1.83B
| $37.1M | ﹤0.01% |
1,307,604
+374,766
| +40% | +$10.6M |
|
1558
US Physical Therapy
USPH
$1.25B
| $36.9M | ﹤0.01% |
327,250
+12,892
| +4% | +$1.46M |
|
1559
Virtus Investment Partners
VRTS
$1.35B
| $36.9M | ﹤0.01% |
148,711
-3,373
| -2% | -$837K |
|
1560
New Fortress Energy
NFE
$381M
| $36.8M | ﹤0.01% |
1,202,470
+39,706
| +3% | +$1.21M |
|
1561
Stantec
STN
$12.7B
| $36.7M | ﹤0.01% |
440,865
+35,017
| +9% | +$2.92M |
|
1562
TTM Technologies
TTMI
$5.08B
| $36.7M | ﹤0.01% |
2,345,168
+52,029
| +2% | +$814K |
|
1563
Gulfport Energy Corp
GPOR
$3.02B
| $36.6M | ﹤0.01% |
228,830
+2,598
| +1% | +$416K |
|
1564
IonQ
IONQ
$13.6B
| $36.6M | ﹤0.01% |
3,667,321
+133,117
| +4% | +$1.33M |
|
1565
Oxford Industries
OXM
$738M
| $36.5M | ﹤0.01% |
324,742
+10,487
| +3% | +$1.18M |
|
1566
Allegro MicroSystems
ALGM
$5.69B
| $36.5M | ﹤0.01% |
1,351,833
+46,322
| +4% | +$1.25M |
|
1567
Kura Oncology
KURA
$727M
| $36.4M | ﹤0.01% |
1,707,274
+51,265
| +3% | +$1.09M |
|
1568
Cimpress
CMPR
$1.47B
| $36.4M | ﹤0.01% |
410,649
+14,137
| +4% | +$1.25M |
|
1569
Hawkins
HWKN
$3.67B
| $36.3M | ﹤0.01% |
472,858
+21,161
| +5% | +$1.63M |
|
1570
Ingevity
NGVT
$2.14B
| $36.3M | ﹤0.01% |
760,638
+22,107
| +3% | +$1.05M |
|
1571
Extreme Networks
EXTR
$3B
| $36.3M | ﹤0.01% |
3,144,084
+112,530
| +4% | +$1.3M |
|
1572
Coursera
COUR
$1.75B
| $36.2M | ﹤0.01% |
2,582,144
+110,628
| +4% | +$1.55M |
|
|
VGR
1573
DELISTED
Vector Group Ltd.
VGR
| $36.2M | ﹤0.01% |
3,301,866
+101,763
| +3% | +$1.12M |
|
1574
Dynavax Technologies
DVAX
$1.12B
| $36.2M | ﹤0.01% |
2,914,693
+93,795
| +3% | +$1.16M |
|
|
ALPN
1575
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $36.1M | ﹤0.01% |
910,599
+146,252
| +19% | +$5.8M |
|